Novus Therapeutics Announces Exercise of Warrants for $4.7 Million Gross Proceeds
IRVINE, Calif.–(BUSINESS WIRE)–$NVUS #otitismedia–Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders…